When documenting inhaled bronchodilators, which detail improves accuracy if a spacer is used?

When documenting inhaled bronchodilators, which detail improves accuracy if a spacer is used?

• A. Time only
• B. Technique, spacer use, time, dose, route
• C. Brand name of device
• D. Patient age

Answer: (B)

When a spacer is used, the accuracy of documenting inhaled bronchodilators depends on capturing all factors that influence how much medication actually reaches the lungs. The technique describes how the patient administers the inhaler with the spacer—whether they coordinate breaths properly, inhale slowly, and hold their breath long enough. Spacer use confirms whether the device helped deliver the dose effectively rather than relying on the inhaler alone. Time records when the dose was given, which matters for monitoring onset and response. Dose notes the amount delivered, accounting for any loss or variation with spacer use. Route confirms that the medication was inhaled via the spacer and not administered by another route. Together, these details provide an accurate picture of what the patient actually received and how well it may work. Listing only the time would miss how technique and spacer use affect delivery, so it can misrepresent the true dose reaching the lungs. The brand name of the device isn’t essential for documenting the delivered medication’s impact, and patient age, while clinically relevant, doesn’t directly improve the accuracy of recording the actual inhaled dose with a spacer.

When a spacer is used, the accuracy of documenting inhaled bronchodilators depends on capturing all factors that influence how much medication actually reaches the lungs. The technique describes how the patient administers the inhaler with the spacer—whether they coordinate breaths properly, inhale slowly, and hold their breath long enough. Spacer use confirms whether the device helped deliver the dose effectively rather than relying on the inhaler alone. Time records when the dose was given, which matters for monitoring onset and response. Dose notes the amount delivered, accounting for any loss or variation with spacer use. Route confirms that the medication was inhaled via the spacer and not administered by another route. Together, these details provide an accurate picture of what the patient actually received and how well it may work.

Listing only the time would miss how technique and spacer use affect delivery, so it can misrepresent the true dose reaching the lungs. The brand name of the device isn’t essential for documenting the delivered medication’s impact, and patient age, while clinically relevant, doesn’t directly improve the accuracy of recording the actual inhaled dose with a spacer.